DOI:
10.1055/s-00034925
Hämostaseologie
LinksClose Window
References
Gisslinger H, Buxhofer-Ausch V, Hodisch J. et al.
A phase III randomized, multicentre, double blind, active controlled trial to compare the efficacy and safety of two different anagrelide formulations in patients with essential thrombocythaemia - the TEAM-ET 2·0 trial.
Br J Haematol 2019;
185 (04) 691-700
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.